← Back to Hub

IVF & Fertility Nursing Guide

GCC Edition

⚠ Female Infertility — Causes & Workup

Common Causes

  • Ovulatory dysfunction — PCOS (70% of anovulation), hypothalamic amenorrhoea, hyperprolactinaemia, thyroid disorders
  • Tubal factor — hydrosalpinx, pelvic adhesions post-infection (Chlamydia, PID), endometriosis
  • Uterine/cervical — submucous fibroids, polyps, Asherman syndrome, cervical stenosis
  • Diminished ovarian reserve (DOR) — advancing age, prior surgery, chemotherapy, genetic (Turner mosaic, FMR1 premutation)
  • Endometriosis — implants affect motility, oocyte quality, implantation
  • Unexplained infertility — approx 15–25% after full workup

Diagnostic Workup — Female

  • Cycle day 2–3: FSH, LH, E2, AMH, AFC (transvaginal US)
  • Mid-luteal progesterone (Day 21) — confirms ovulation
  • TSH, prolactin, fasting androgens (DHEAS, testosterone)
  • Hysterosalpingography (HSG) — tubal patency
  • Diagnostic hysteroscopy — uterine cavity
  • Karyotype if recurrent pregnancy loss (RPL) or POI
  • Thrombophilia screen (Factor V Leiden, APLA) for RPL

📊 Ovarian Reserve Reference Ranges

TestNormal ReserveDiminished ReserveHigh Reserve / Risk
AMH (Anti-Mullerian Hormone)1.5 – 4.0 ng/mL< 1.0 ng/mL> 4.5 ng/mL (OHSS risk)
AFC (Antral Follicle Count)7 – 15 follicles< 5–7 follicles> 20 follicles (PCO morphology)
Day 3 FSH< 10 IU/L> 10–12 IU/L—
Day 3 Oestradiol (E2)< 60–80 pg/mL> 80 pg/mL (false-low FSH)—
Clomiphene Challenge Test (CCCT)Day 10 FSH < 10Day 10 FSH > 10—
AMH is cycle-day independent — most reliable single ovarian reserve marker. Correlates with AFC and predicted oocyte yield.

♂ Male Infertility — Causes & Semen Analysis

Common Causes

  • Varicocele — most common correctable cause (35–40%)
  • Obstructive azoospermia — vasectomy, congenital bilateral absent vas (CBAVD linked to CFTR), post-infection stricture
  • Non-obstructive azoospermia (NOA) — Klinefelter (47XXY), AZF microdeletions, cryptorchidism, chemotherapy
  • Endocrine — hypogonadotrophic hypogonadism (Kallmann), hyperprolactinaemia
  • Idiopathic oligoasthenoteratospermia (OAT)
  • Antisperm antibodies

WHO 2021 Semen Analysis Reference Limits

ParameterLower Limit
Volume≥ 1.4 mL
Sperm concentration≥ 16 × 10⁶/mL
Total motility (PR + NP)≥ 42%
Progressive motility (PR)≥ 30%
Morphology (Kruger strict)≥ 4% normal forms
Total sperm number≥ 39 × 10⁶ / ejaculate
Vitality (live)≥ 54%

📋 PCOS — Rotterdam Criteria (2003)

Diagnosis requires 2 of 3 criteria:

1. Oligo/Anovulation

<8 cycles/year or cycles >35 days; absent LH surge on tracking

2. Clinical/Biochemical Hyperandrogenism

Hirsutism (Ferriman-Gallwey ≥8), acne, elevated free testosterone/DHEAS; exclude CAH, Cushing, androgen tumour

3. Polycystic Ovarian Morphology (PCOM)

AFC ≥20 per ovary OR ovarian volume ≥10 mL on transvaginal US (exclude dominant follicle, CL)

PCOS in GCC populations: higher prevalence (~18–20%), often presenting with severe insulin resistance; screen fasting glucose, HOMA-IR, lipid profile. Vitamin D deficiency common — check 25-OH vitamin D.

💉 Controlled Ovarian Stimulation (COS)

GnRH Agonist (Long) Protocol

1
Downregulation — GnRH agonist (buserelin/leuprolide) started Day 21 of previous cycle. Confirmed by E2 <50 pg/mL + endometrial thickness <5 mm + quiet ovaries.
2
Stimulation — FSH/hMG started (typically Day 2–3). Common doses: 150–300 IU/day based on AFC/AMH/age/BMI.
3
Monitoring — Follicle tracking by US Day 5–6 then every 1–2 days. Serum E2 to guide dose adjustment.
4
Trigger — hCG 5,000–10,000 IU (or recombinant hCG 250 mcg) when ≥3 follicles ≥17–18 mm. OHSS risk: use GnRH agonist trigger instead.
Advantages: well-established, prevents premature LH surge
Risk: OHSS, longer protocol, higher drug cost

GnRH Antagonist Protocol

1
Stimulation Day 1–2 — FSH/hMG started without prior downregulation. Flexible or fixed start protocol.
2
Antagonist added — Cetrorelix/ganirelix 0.25 mg/day SC from Day 5–6 of stimulation OR when lead follicle ≥12–14 mm (flexible protocol).
3
Monitoring — Same as agonist protocol; E2 + follicle tracking every 1–2 days.
4
Trigger — GnRH agonist trigger (0.5 mg buserelin SC) preferred in high-risk (PCOS, AFC >20, AMH >4) to reduce OHSS while allowing freeze-all strategy.
Advantages: shorter, safer (agonist trigger option), OHSS reduction
Preferred: PCOS patients, high responders

📈 Trigger Injection — Types & Nursing Points

Trigger TypeDoseTimingBest ForOHSS Risk
Urinary hCG (Pregnyl, Profasi)5,000–10,000 IU SC/IMExact time — OPU 34–36 hrs laterAgonist protocol, normal respondersHigh
Recombinant hCG (Ovitrelle)250 mcg SCExact time — OPU 34–36 hrs laterAgonist protocol, more predictableHigh
GnRH Agonist (Buserelin, Triptorelin)0.2–0.5 mg SCExact time — OPU 34–36 hrs laterAntagonist protocol, PCOS, high respondersLow
Dual Trigger (hCG + GnRH-a)Standard doses combinedSimultaneous, exact timePoor responders (IVF optimisation)Moderate
CRITICAL NURSING POINT: Trigger timing is absolute. A 1-hour deviation can result in premature ovulation (lost oocytes) or immature retrieval. Confirm patient understanding with written + verbal instructions; document exact administration time.

💊 Oocyte Retrieval (OPU) — Pre-procedural Nursing

Pre-procedure Checklist

  • Confirm nil by mouth (4–6 hrs for sedation)
  • Verify trigger time documentation and OPU schedule
  • IV access (antecubital or dorsal hand)
  • Consent signed (including ICSI, embryo freezing if applicable)
  • Allergies confirmed — iodine, latex, sedation agents
  • Empty bladder before procedure
  • Baseline vitals; SpO2, BP, pulse
  • Confirm escort for discharge — sedation policy
  • Pre-procedure vaginal preparation (discuss antiseptic vs saline with team)

Post-procedure Recovery

  • Monitor recovery: SpO2, BP, pain (PARS score)
  • Expect: mild pelvic cramping, light spotting — reassure
  • Discharge criteria: alert, stable vitals, tolerating fluids, voided
  • Warn: heavy bleeding, fever >38°C, severe pain → contact clinic immediately
  • Report oocyte number to patient after embryologist communication
  • Discharge with luteal support prescription
  • No intercourse until post-OPU follow-up
Rare but serious: intraperitoneal haemorrhage from ovarian vessel injury. Signs: severe pain, falling Hb, haemodynamic instability.

💊 Luteal Phase Support

Progesterone Options

RouteExampleDoseNotes
Vaginal pessaryCyclogest, Utrogestan400–800 mg/dayFirst-line; minimal systemic SE
Vaginal gelCrinone 8%Once dailyGood compliance
IM injectionProgesterone in oil50 mg/dayPainful; used if vaginal contraindicated
SubcutaneousProlutex25 mg/dayWell tolerated, expensive
OralUtrogestan oral200–300 mg/dayAdjunct only; poor bioavailability

Adjuncts

  • Oestradiol (valerate/patches) — for frozen-thawed ET cycles
  • Aspirin 75–100 mg/day — some protocols for uterine blood flow
  • hCG supplementation — used cautiously in agonist cycles (OHSS risk)
  • GnRH agonist (low dose) — luteal rescue in some antagonist protocols

Duration

Continue until 10–12 weeks gestation if positive hCG; taper after first trimester once placenta established. Never stop abruptly — taper under physician direction.

🚨 OHSS Classification

Mild OHSS

  • Abdominal bloating
  • Mild discomfort
  • Ovarian size <8 cm
  • No free fluid
  • Manage: outpatient, oral fluids, analgesia

Moderate OHSS

  • Nausea ± vomiting
  • Abdominal distension
  • US: free fluid in pelvis
  • Ovaries 8–12 cm
  • Manage: close monitoring, IV fluids if needed

Severe OHSS

  • Tense ascites
  • Haematocrit >45%
  • WBC >15,000
  • Ovaries >12 cm
  • Oliguria (<300 mL/day)
  • Admit for IV fluid therapy

Critical OHSS

  • Renal failure
  • Thromboembolism
  • ARDS / pleural effusion
  • Haematocrit >55%
  • HDU / ITU admission
  • Consider paracentesis

📌 Early vs Late OHSS

Early OHSS (within 9 days of trigger)

  • Triggered by exogenous hCG (trigger injection)
  • Onset: 3–9 days post-trigger
  • If pregnancy does not occur → resolves spontaneously
  • Prevention: GnRH agonist trigger in antagonist cycles
  • Freeze-all embryo strategy avoids endogenous hCG exposure

Late OHSS (after Day 9–12)

  • Triggered by rising endogenous hCG from implantation
  • Indicates pregnancy — often more severe and prolonged
  • Onset: 12–17 days post-OPU
  • Cannot be prevented by GnRH-a trigger alone — pregnancy sustains it
  • May persist into first trimester; worse with multiple pregnancy
GnRH agonist trigger eliminates early OHSS risk by avoiding exogenous hCG. Requires freeze-all strategy; fresh ET contraindicated due to poor luteal support and ongoing OHSS risk.

📋 Nursing Monitoring Parameters

Daily Monitoring (Inpatient Severe/Critical)

ParameterFrequencyAlert Threshold
Abdominal girthEvery 12 hrsIncrease >3 cm in 24 hrs
Daily weightEvery 24 hrs (same time)Gain >1 kg/24 hrs
Fluid balanceStrict hourly urine outputUO <30 mL/hr for 2 hrs
HaematocritDaily (BD if severe)>45% (severe), >55% (critical)
Creatinine / eGFRDailyRising trend or Cr >133 µmol/L
ElectrolytesDailyHyponatraemia <130, hyperkalaemia
WBCDaily>25,000 (severe response)
SpO2Continuous if severe<95%

Fluid Management

  • Goal: maintain UO ≥30 mL/hr
  • IV albumin 20% (50–100 mL) — first-line colloid to expand intravascular volume and draw third-space fluid
  • Caution with crystalloids — risk of worsening ascites/third-spacing
  • Strict input-output charting — include ascitic drainage

Ascites Management

  • Therapeutic paracentesis — transvaginal or abdominal route
  • Indications: respiratory compromise, severe pain, oliguria unresponsive to albumin
  • Nursing: position patient comfortably, mark drainage volume, monitor post-procedure vitals
  • Drain 2–3 L slowly; reassess for re-accumulation
THROMBOPROPHYLAXIS: Enoxaparin (LMWH) is mandatory in hospitalised OHSS patients. Haemoconcentration + immobility = high VTE risk. Teach injection technique; continue until mobile and fluid mobilised.

📈 OHSS Risk Score Calculator

🚨 Critical Nursing Interventions Summary

Prevent

  • Identify high-risk patients pre-stimulation (PCOS, AMH >4, AFC >20)
  • Recommend antagonist protocol for high-risk
  • GnRH agonist trigger + freeze-all strategy
  • Coasting (withhold gonadotrophins) when E2 very high
  • Cycle cancellation in extreme cases

Treat

  • IV albumin 20% for intravascular expansion
  • LMWH thromboprophylaxis (anti-embolic stockings)
  • Anti-emetics, analgesics (avoid NSAIDs in early pregnancy)
  • Paracentesis for symptomatic ascites
  • Dopamine at low dose (renal dose) for oliguria — if prescribed
  • Monitor for complications: VTE, ARDS, ovarian torsion, renal failure

💌 Fresh vs Frozen-Thawed Embryo Transfer (FET)

Fresh ET

  • Transfer Day 3 (cleavage) or Day 5 (blastocyst) post-OPU
  • Natural luteal support from stimulation cycle
  • Endometrium may be sub-optimal after heavy stimulation (E2 excess)
  • Avoided in: OHSS risk, elevated progesterone on trigger day, polyps/fluid
  • Simpler logistics — single cycle

Frozen-Thawed ET (FET)

  • Allows full endometrial recovery; optimal implantation window
  • Preferred for OHSS risk, PGT (preimplantation genetic testing), elevated P4 on trigger day
  • Natural FET: monitor LH surge/follicle; ET day based on ovulation
  • Artificial/Programmed FET: oestradiol valerate → USS confirmation → add progesterone 5 days before ET
  • Blastocyst vitrification survival rate >95% in modern labs

Endometrial Preparation Monitoring (Programmed FET)

VisitAssessmentAction
Day 2–3Baseline US + E2Start oestradiol 6 mg/day oral or patches
Day 8–10Endometrial thickness + patternTarget: ≥7 mm trilaminar (triple-line)
Pre-progesteroneFinal US + E2 (aim >200 pg/mL)If adequate: start progesterone
ET DayFinal check US (no fluid, thickness)Proceed or defer

Post-Transfer Instructions

  • Rest 30–60 min post-procedure (centre policy varies)
  • Continue progesterone support — emphasise not to stop
  • Light activity for 24–48 hrs; avoid strenuous exercise
  • Sexual intercourse: usually restricted until beta-hCG
  • Normal daily activities from Day 2 post-ET
  • Avoid hot baths, saunas, high fever situations
  • Report: heavy bleeding, severe pain, fever — do not wait for scheduled visit
  • Beta-hCG blood test: Day 9–14 post-ET
Avoid urine pregnancy tests before Day 12–14 — false positives from trigger hCG (if used), and false negatives too early.

📈 Beta-hCG Interpretation & Doubling Calculator

First beta-hCG: typically Day 9–12 post-ET. Doubling time normal: <48–72 hours in early viable intrauterine pregnancy.

Beta-hCG LevelInterpretation
<5 IU/LNegative
5–25 IU/LEquivocal — repeat 48 hrs
>25 IU/L (Day 9)Positive — monitor trend
>1000–1500 IU/LUS discriminatory zone — expect gestational sac
>6500 IU/LFoetal heartbeat expected on US
Slow-rising hCG (<53% rise in 48 hrs) suggests ectopic, biochemical pregnancy, or failing IUP. Refer for urgent review.

Beta-hCG Doubling Calculator

🌍 IVF Regulations by GCC Country

🇦🇪

Saudi Arabia (KSA)

IVF permitted exclusively for legally married heterosexual couples. Islamic fatwa (NCBE 1985) permits IVF using husband's sperm and wife's oocyte only. Gamete donation strictly prohibited. Surrogacy prohibited. Embryo freezing permitted. All centres must be licensed by Ministry of Health (MOH). Saudi Commission for Health Specialties (SCFHS) oversees fertility specialists. Genetic screening (PGT) allowed for hereditary diseases with MOH approval.

🇦🇪

United Arab Emirates (UAE)

Regulated under Federal Law No. 11 (2008) — IVF for married couples using own gametes only. MOHAP (Ministry of Health and Prevention) licenses all ART centres. Abu Dhabi DOH and Dubai Health Authority (DHA) have additional oversight. Embryo freezing, ICSI, PGT widely available. Third-party donation and surrogacy prohibited. Major centres: IVF.ae, Bourn Hall Dubai, ICSI Fertility, Fakih IVF (Abu Dhabi), Al Ain Fertility Centre.

🇶🇦

Qatar

Supreme Council of Health oversees ART services. IVF for married couples only — own gametes required. Hamad Medical Corporation (HMC) leads fertility services. Sharia-compliant regulations similar to KSA. Embryo freezing for personal use permitted. PGT available for genetic disease prevention. No donor gametes or surrogacy.

🇰🇼

Kuwait

Ministry of Health regulates ART. IVF permitted for married couples using their own gametes. Law No. 34/1987 governs medical practice; ART follows Islamic guidance. Bneid Al-Gar Hospital and private centres offer IVF. Third-party reproduction prohibited. Embryo freezing commonly practiced.

🇧🇭

Bahrain

National Health Regulatory Authority (NHRA) licenses IVF centres. IVF for married couples; own gametes only. Comparatively more liberal in accessibility of ART services. Private clinics (e.g., BNH, Bahrain Specialist Hospital fertility unit) operate under NHRA. No gamete donation or surrogacy.

🇴🇲

Oman

Ministry of Health regulates ART. IVF for married couples using own gametes. Royal Hospital Muscat and private clinics offer services. Islamic principles govern all ART decisions. No donor gametes or surrogacy. Embryo freezing permitted within Islamic guidelines.

💤 Religious & Ethical Considerations

Islamic Perspective on IVF

  • IVF using own gametes within marriage is permitted (halal) — confirmed by Islamic Fiqh Academy (OIC, 1986)
  • Egg and sperm must be from husband and wife only
  • Third-party gametes create questions of lineage (nasab) — prohibited
  • Embryo reduction: controversial — scholarly debate; generally discouraged except life-threatening circumstances
  • Sex selection for medical (PGT) purposes: permitted in many GCC centres; social sex selection: prohibited or restricted
  • Unused embryos: must not be deliberately destroyed; donation to research restricted; adoption of embryo by another couple prohibited

Religious Counselling Role of the Nurse

  • Facilitate access to religious scholar (Imam/Mufti) consultations if couple requests
  • Respect that some couples require fatwa (religious ruling) before consenting to certain procedures
  • Do not impose personal religious views; maintain cultural sensitivity
  • Ramadan scheduling: many couples prefer to avoid IVF during Ramadan; support rescheduling requests
  • Gender-appropriate care: female nurse/physician preferred by many GCC women — organise proactively
  • Privacy/confidentiality paramount — infertility is deeply private in GCC culture; family disclosure should be patient-led

🏠 Leading GCC Fertility Centres

IVF.ae (Dubai)

Dedicated IVF centre, DHA licensed. Offers full ART services, PGT-A, vitrification, and fertility preservation for oncology patients.

Bourn Hall Dubai

Internationally recognised (Cambridge origins). Offers IVF, ICSI, blastocyst culture, frozen embryo transfer. DHA licensed.

Al Ain Fertility Centre (UAE)

Long-established in Abu Dhabi Emirate. Caters to Emirati and expatriate population. MOHAP licensed.

Fakih IVF (Abu Dhabi / Dubai)

One of UAE's largest ART networks. Extensive experience, multilingual team, Islamic advisory board.

King Faisal Specialist Hospital (Riyadh)

Comprehensive reproductive medicine unit. MOH/NCBE compliant. Serves Saudi nationals and expatriates.

Hamad Medical Corp Fertility (Qatar)

Leading public fertility services in Qatar. Part of HMC network. Sharia-compliant ART under MOH oversight.

💉 Injection Technique Training

Subcutaneous Injection — Step-by-Step

  1. Wash hands thoroughly (20 seconds)
  2. Check medication: name, dose, expiry date, clarity
  3. Allow refrigerated medication to reach room temperature (30 min)
  4. Gather supplies: medication, pen/syringe, alcohol swab, sharps bin
  5. Choose site: abdomen (5 cm from navel), upper outer thigh, or upper arm
  6. Rotate injection sites — document rotation chart
  7. Cleanse skin with alcohol swab; allow to dry completely (15–30 sec)
  8. Pinch 2–3 cm of skin between thumb and index finger
  9. Insert needle at 90° (or 45° if thin patient) with smooth motion
  10. Do not aspirate — subcutaneous injections do not require aspiration
  11. Inject medication at steady pace
  12. Remove needle; apply gentle pressure (do not rub — reduces bruising)
  13. Dispose in sharps container immediately

Common Concerns & Responses

ConcernNurse Response
Needle phobiaPen devices available; autoinjectors; desensitisation counselling; partner training
Bruising/rednessNormal; rotate sites; cold compress before injection; avoid same spot
Missed doseContact clinic immediately; do not double dose; protocol-specific guidance
Medication ran out earlyEmergency prescription; never skip FSH dose — follicular development depends on continuous stimulation
Air bubble in syringeSmall bubbles (SC): safe, harmless. Remove large bubbles by pointing up and tapping gently

❄️ Medication Storage Guidelines

FSH / LH Preparations

Store 2–8°C (refrigerator). Do NOT freeze. Once reconstituted/opened: use within 28 days (pen) or immediately (vial). Keep away from direct light. Examples: Gonal-F, Bemfola, Puregon, Menopur.

GnRH Agonists/Antagonists

Room temperature (up to 25°C) for most preparations. Nasal sprays: store upright. Cetrorelix/ganirelix pre-filled syringes: refrigerate until use then allow to warm slightly. Check package insert for each brand.

hCG Trigger & Progesterone

hCG powder: room temperature; reconstitute with provided solvent immediately before use. Ovitrelle pre-filled pen: refrigerate. Cyclogest pessaries: below 25°C, away from heat. Progesterone in oil: room temperature.

Never use medications that have been frozen (unless specifically designed for freezing), exposed to heat >30°C, or are beyond expiry. GCC summer temperatures in cars can exceed 60°C — NEVER leave medications in a vehicle.

🌿 Lifestyle Advice

BMI & Weight

  • Optimal BMI for IVF: 18.5–25 kg/m²
  • BMI >30: reduced response, higher miscarriage risk, anaesthetic risk at OPU
  • BMI <18.5: hypothalamic suppression, reduced oocyte quality
  • 5–10% weight loss in overweight women with PCOS can restore ovulation
  • GCC note: obesity prevalence high (40–50%); sensitive, non-judgmental counselling essential

Supplements

  • Folic acid 400 mcg/day (start before treatment; 5 mg if high-risk)
  • Vitamin D — check 25-OH level; supplement if <30 ng/mL (common in GCC due to indoor lifestyle)
  • CoQ10 (ubiquinol) 200–600 mg/day — some evidence for oocyte quality in DOR
  • Omega-3: 1–2 g/day — general health; potential anti-inflammatory benefit
  • Avoid high-dose antioxidants during stimulation unless prescribed

Smoking & Substances

  • Smoking: reduces ovarian reserve, impairs fertilisation and implantation — cessation mandatory
  • Passive smoking: also harmful — encourage partner cessation
  • Alcohol: complete abstinence recommended during IVF treatment
  • Caffeine: limit to <200 mg/day (1–2 cups coffee)
  • Recreational drugs: strictly avoid — legal issues in GCC also apply

Exercise & Activity

  • Moderate exercise (walking, yoga, swimming): safe and beneficial
  • High-intensity: avoid during stimulation — enlarged ovaries = torsion risk
  • Post-OPU: light activity only for 3–5 days; avoid core exercises
  • Post-ET: gentle walking; avoid strenuous exercise until beta-hCG confirmed

Diet

  • Mediterranean-style diet: evidence for improved IVF outcomes
  • Increase: leafy greens, legumes, wholegrains, fish, olive oil
  • Reduce: processed foods, trans fats, high-sugar foods, red meat

💕 Psychological Support & Cultural Sensitivity

Psychological Burden

  • IVF is emotionally, physically, and financially taxing
  • Screen for anxiety and depression at baseline and during treatment (PHQ-9, GAD-7)
  • Miscarriage after IVF: grief counselling; acknowledge loss
  • Failed cycle: normalise feelings; allow time before discussing next steps
  • Offer referral to fertility counsellor / psychologist — normalise this in your language
  • Mindfulness and stress-reduction programs: evidence supports improved wellbeing (not necessarily outcomes)

GCC Cultural Sensitivity

  • Infertility stigma: often internalised; women may feel personal shame or social pressure
  • Couple may not have disclosed fertility treatment to family — confidentiality is critical
  • Male factor infertility: particularly sensitive topic for husbands; approach with respect and privacy
  • Provide information in Arabic where possible; use certified medical interpreters (not family members) for consent
  • Prayer times: schedule appointments around salah when possible
  • Ramadan: many patients prefer to pause IVF during fasting month — offer flexible scheduling
  • Female healthcare providers: accommodate requests without judgment
  • Extended family involvement: patient decides what is shared; do not engage family without explicit consent

🎓 Practice Questions (10 MCQs)